Vaccine Scheduler

Greece: Recommended vaccinations

	General recommendation
	Recommendation for specific groups only
	Catch-up (e.g. if previous doses missed)
	Vaccination not funded by the National Health system
	Mandatory vaccination

	Birth	Months											Years
	Birth	2	3	4	5	6	11	12	15	18	19	23	2-3	4	5	6	7	9	10	11	12	13	15	18
tuberculosis	BCG⁶

rotavirus infection¹		ROTA		ROTA		ROTA

diphtheria		D		D		D		D	D		D			D			d			d		d
tetanus		TT		TT		TT		TT	TT		TT			TT			TT			TT		TT
pertussis		acP		acP		acP		acP	acp		acp			acP			acp			acp		acp
poliomyelitis		IPV		IPV		IPV					IPV			IPV			IPV
Haemophilus influenzae type b infection		Hib		Hib		Hib		Hib	Hib		Hib					Hib
hepatitis B	HepB⁷	HepB		HepB		HepB					HepB

pneumococcal disease²		PCV15 or PCV20		PCV15 or PCV20				PCV15 or PCV20⁸																PCV20

meningococcal disease³		MCV4/MenB						MenC	MenC											MCV4		MCV4

measles⁴								MEAS		MEAS			MEAS	MEAS
mumps								MUMPS		MUMPS			MUMPS	MUMPS
rubella								RUBE		RUBE			RUBE	RUBE

varicella								VAR		VAR			VAR	VAR

human papillomavirus infection																		HPV9 (F/M)⁹					HPV9 (F/M)¹⁰

influenza						IIV3¹¹

herpes zoster⁵																								ZOS¹²

hepatitis A													HepA				HepA

Version:

Footnotes:

2 doses of RV1 (month 2 and 4) OR 3 doses of RV5 (month 2, 4 and 6)
PPSV23 recommended from 2 years of age in at-risk groups
MenACWY is recommended to all adolescents aged 11-12 years. It is also recommended to infants and children (aged 2 months to 18 years) in increased risk categories. Infants starting vaccination at 2 to 6 months of age are recommended 3 doses at ages 2, 4 and 12 months (MenACWY-TT vaccine); Infants starting vaccination between 7 and 24 months: 2 doses, 2nd dose to is administered at least 12 weeks after the first dose (MenACWY-TT vaccine); Children starting vaccination after 2 years of age: 2 doses with 8 weeks interval (MenACWY-CRM or MenACWY-TT vaccine); In children who remain at high risk, a booster dose is recommended 3-5 years after completion of their primary course. The MenB vaccine is recommended to infants and children (aged 2 months to 18 years) in increased risk categories. Infants starting vaccination at 2 to 5 months of age are recommended 4 doses at ages 2, 4, 6 and 12–15 months (MenB-4C); Infants and toddlers starting vaccination at 6 to 23 months of age: 2 doses with minimum 8 weeks interval and a booster dose at age 12–23 months (MenB-4C); Children starting vaccination at 2 to 10 years of age: 2 doses with minimum 8 weeks interval (MenB-4C); Children starting vaccination from the age of 11 years: 2 doses with minimum interval of 1 month (MenB-4C); Individuals aged 10 years and above can be vaccinated with MenB-fHbp with a 3-dose regimen at 0, 1–2, 6 months. More details available at: http://www.infovac.gr/wp-content/uploads/2019/06/%CE%95%CE%98%CE%9D%CE%99%CE%9A%CE%9F-%CE%A0%CE%A1%CE%9F%CE%93%CE%A1%CE%91%CE%9C%CE%9C%CE%91-%CE%95%CE%9C%CE%92%CE%9F%CE%9B%CE%99%CE%91%CE%A3%CE%9C%CE%A9%CE%9D-%CE%A0%CE%91%CE%94%CE%99%CE%A9%CE%9D-%CE%95%CE%A6%CE%97%CE%92%CE%A9%CE%9D-2019.pdf
21 Sept. 2017: temporary recommendation for measles vaccination in Greece. First Dose at 12 months of age, Second dose 3 months later or 4 weeks after Dose 1 in specific groups
for detailled information refer to https://www.moh.gov.gr/articles/health/dieythynsh-dhmosias-ygieinhs/emboliasmoi/alles-systaseis-ths-ethnikhs-epitrophs-emboliasmwn/11437-skeptiko-emboliasmoy-gia-ton-erphta-zwsthra-aprilios-2023
Vaccination is also recommended for infants and children up to the age of 5 years who belong to an increased risk groups and who have not been previously vaccinated
Babies born to a mother infected with hepatitis B (or with unknown status) will be offered a first vaccine dose at birth simultaneously with HB immunoglobulin. More details on follow-up schedule are available at: http://www.infovac.gr/wp-content/uploads/2019/06/%CE%95%CE%98%CE%9D%CE%99%CE%9A%CE%9F-%CE%A0%CE%A1%CE%9F%CE%93%CE%A1%CE%91%CE%9C%CE%9C%CE%91-%CE%95%CE%9C%CE%92%CE%9F%CE%9B%CE%99%CE%91%CE%A3%CE%9C%CE%A9%CE%9D-%CE%A0%CE%91%CE%94%CE%99%CE%A9%CE%9D-%CE%95%CE%A6%CE%97%CE%92%CE%A9%CE%9D-2019.pdf
When PCV20 is selected, the recommended schedule consists of 3 primary doses + 1 booster dose (3+1).
Catch-up vaccination up to 18 years for those who missed out on vaccination (HPV vaccine is fully reimbursed in boys and girls aged 15-18 until 31.12.2023). 2 doses scheme up to 15 years with 6 months interval between doses, thereafter 3 doses. for specific at-risk groups vaccination can be extended up to 26 years.
Catch-up vaccination up to 18 years for those who missed out on vaccination (HPV vaccine is fully reimbursed in boys and girls aged 15-18 until 31.12.2025). 2 doses scheme up to 18 years. for specific at-risk groups vaccination can be extended up to 26 years.
Since 2024 flu vaccination is recommended to all children between 6 months -5 years of age. In addition, Greece has recommendations for children and adolescents belonging to high-risk groups. Source: https://www.moh.gov.gr/articles/health/dieythynsh-dhmosias-ygieinhs/emboliasmoi/ethniko-programma-emboliasmwn-epe-paidiwn-kai-efhbwn
2 doses (RZV vaccine) in immunocompromised with 2 or more episodes of herpes-zoster

More information available at:
https://www.moh.gov.gr/articles/health/dieythynsh-dhmosias-ygieinhs/emboliasmoi/

Last update : 21 January 2025